These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6210954)

  • 1. In vitro enhancement of AA-degrading activity in human plasma with the plasminogen activator streptokinase.
    Skogen B; Natvig JB
    Scand J Immunol; 1981 Dec; 14(6):637-41. PubMed ID: 6210954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of amyloid proteins by different serine proteases.
    Skogen B; Natvig JB
    Scand J Immunol; 1981 Oct; 14(4):389-96. PubMed ID: 6461061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-plasminogen antibody preparation that inhibits the activation of human plasminogen but enhances the activator activity of the B-chain-streptokinase complex.
    Summaria L; Pavlovic B; Sandesara J
    Thromb Res; 1989 Apr; 54(1):1-15. PubMed ID: 2727955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the stimulatory effect of 6-aminohexanoic acid on plasminogen activation by streptokinase or tissue plasminogen activator: the role of chloride.
    Guinn L; Doctor VM
    Eur J Drug Metab Pharmacokinet; 2003; 28(4):315-20. PubMed ID: 14743974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonantigenic covalent streptokinase-polyethylene glycol complex with plasminogen activator function.
    Rajagopalan S; Gonias SL; Pizzo SV
    J Clin Invest; 1985 Feb; 75(2):413-9. PubMed ID: 3156148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin.
    Ts'ao C; Galluzzo TS
    Am J Clin Pathol; 1981 Mar; 75(3):372-7. PubMed ID: 6452054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Theoretical bases of thrombolytic therapy].
    Verstraete M
    Pathol Biol (Paris); 1975 Mar; 23(3):239-45. PubMed ID: 124849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of antibody binding in vitro on the pharmacological properties of anisoylated plasminogen streptokinase activator complex.
    Fears R; Ferres H; Hibbs M; Standring R
    Drugs; 1987; 33 Suppl 3():64-8. PubMed ID: 3315614
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of five streptokinase formulations using the euglobulin lysis test and the plasminogen activation assay.
    Couto LT; Donato JL; de Nucci G
    Braz J Med Biol Res; 2004 Dec; 37(12):1889-94. PubMed ID: 15558196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on activator formation in human plasma with streptokinase. III. Investigation of activator kinetics in undiluted plasma in terms of urokinase equivalents.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):566-81. PubMed ID: 138962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic mechanism of the activation of human plasminogen by streptokinase.
    Kosow DP
    Biochemistry; 1975 Oct; 14(20):4459-65. PubMed ID: 126078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and its thiolactone impair plasmin activity induced by urokinase or streptokinase in vitro.
    Kolodziejczyk-Czepas J; Talar B; Nowak P; Olas B; Wachowicz B
    Int J Biol Macromol; 2012 Apr; 50(3):754-8. PubMed ID: 22197896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of immobilized human plasminogen and plasmin with streptokinase.
    Shi GY; Chang BI; Wu DH; Wu HL
    Biochem Biophys Res Commun; 1993 Aug; 195(1):192-200. PubMed ID: 8363600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasminogen determination, using a chromogenic tripeptidic substrate (author's transl)].
    Soria J; Soria C; Samama M
    Pathol Biol (Paris); 1976 Dec; 24(10):725-9. PubMed ID: 138119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the reliability of plasminogen measurement employing the proactivator-activator converting method.
    Martin M
    Thromb Haemost; 1976 Dec; 36(3):551-65. PubMed ID: 138961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activation kinetics of mammalian plasminogens.
    Wohl RC; Sinio L; Summaria L; Robbins KC
    Biochim Biophys Acta; 1983 May; 745(1):20-31. PubMed ID: 6682680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Animal experimental studies on fibrinolysis with streptokinase].
    Hauptmann J; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):915-22. PubMed ID: 94886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of streptokinase by affinity chromatography on immobilized acylated human plasminogen.
    Rodríguez P; Hernàndez L; Muñoz E; Castro A; de la Fuente J; Herrera L
    Biotechniques; 1992 Mar; 12(3):424-9. PubMed ID: 1533307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.